Tap the share icon below and choose add to homescreen. Tap the share icon above and choose add to homescreen. Tap the share icon below and choose add to homescreen. Tap the share icon below and choose add to homescreen.
Dr. Hartley is a paid consultant to Medima Health, Inc. Other authors declare no competing interests.
The Medima P300: A Unified Point-of-Care Platform for Multi-Modal Biosensing, AI-Driven Diagnostics, and Closed-Loop Therapeutics in Critical and Remote Care medima p300
Point-of-care diagnostics, artificial intelligence in medicine, closed-loop therapy, sepsis detection, Raman spectroscopy, microfluidics. 1. Introduction The "golden hour" of emergency medicine—the critical 60 minutes following traumatic injury or acute illness—demands interventions that are both rapid and precise. Yet, current workflows remain fragmented: blood draws are sent to central labs (turnaround 45–120 min), imaging requires bulky equipment, and infusions are manually titrated by overburdened staff. In low- and middle-income countries (LMICs), the situation is more acute, with a severe shortage of laboratory infrastructure and specialists. The Medima P300: A Unified Point-of-Care Platform for
A. Hartley, PhD; S. Chen, MD; L. M. Rodriguez, PhD; K. I. Tanaka, MD (Affiliation: Institute for Integrated Medical Devices, University of Global Health) Yet, current workflows remain fragmented: blood draws are
